These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21726198)

  • 21. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.
    Swiatecka-Urban A; Duhaime M; Coutermarsh B; Karlson KH; Collawn J; Milewski M; Cutting GR; Guggino WB; Langford G; Stanton BA
    J Biol Chem; 2002 Oct; 277(42):40099-105. PubMed ID: 12167629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane.
    Li C; Roy K; Dandridge K; Naren AP
    J Biol Chem; 2004 Jun; 279(23):24673-84. PubMed ID: 15060073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of CFTR interactome in the macromolecular complexes.
    Li C; Naren AP
    Methods Mol Biol; 2011; 741():255-70. PubMed ID: 21594790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFTR inhibitors.
    Verkman AS; Synder D; Tradtrantip L; Thiagarajah JR; Anderson MO
    Curr Pharm Des; 2013; 19(19):3529-41. PubMed ID: 23331030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane.
    Milewski MI; Mickle JE; Forrest JK; Stafford DM; Moyer BD; Cheng J; Guggino WB; Stanton BA; Cutting GR
    J Cell Sci; 2001 Feb; 114(Pt 4):719-26. PubMed ID: 11171377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
    Ahner A; Frizzell RA
    Curr Drug Targets; 2015; 16(9):965-75. PubMed ID: 26028049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors.
    Al-Awqati Q
    J Clin Invest; 2002 Dec; 110(11):1599-601. PubMed ID: 12464662
    [No Abstract]   [Full Text] [Related]  

  • 28. Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.
    Holt GT; Jou JD; Gill NP; Lowegard AU; Martin JW; Madden DR; Donald BR
    J Phys Chem B; 2019 Dec; 123(49):10441-10455. PubMed ID: 31697075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
    Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
    Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.
    Kundu R; Cushing PR; Popp BV; Zhao Y; Madden DR; Ball ZT
    Angew Chem Int Ed Engl; 2012 Jul; 51(29):7217-20. PubMed ID: 22700245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug discovery and epithelial physiology.
    Verkman AS
    Curr Opin Nephrol Hypertens; 2004 Sep; 13(5):563-8. PubMed ID: 15300164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CFTR:a multifaceted epithelial molecule.
    Tümmler B; Puchelle E
    Trends Cell Biol; 1997 Jun; 7(6):250-1. PubMed ID: 17708954
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis.
    Lim SH; Legere EA; Snider J; Stagljar I
    Front Pharmacol; 2017; 8():997. PubMed ID: 29403380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
    Schneider EK; Reyes-Ortega F; Li J; Velkov T
    Clin Pharmacol Ther; 2017 Jan; 101(1):130-141. PubMed ID: 27804127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability.
    Meng X; Clews J; Kargas V; Wang X; Ford RC
    Cell Mol Life Sci; 2017 Jan; 74(1):23-38. PubMed ID: 27734094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane regulator correctors and potentiators.
    Rowe SM; Verkman AS
    Cold Spring Harb Perspect Med; 2013 Jul; 3(7):. PubMed ID: 23818513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CFTR-SLC26 transporter interactions in epithelia.
    Fong P
    Biophys Rev; 2012 Jun; 4(2):107-116. PubMed ID: 22685498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.
    Zhang W; Fujii N; Naren AP
    Future Med Chem; 2012 Mar; 4(3):329-45. PubMed ID: 22393940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the regulation of CFTR channels.
    Eckford PD; Bear CE
    Biochem J; 2011 Apr; 435(2):e1-4. PubMed ID: 21726198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CFTR-NHERF2-LPA₂ Complex in the Airway and Gut Epithelia.
    Zhang W; Zhang Z; Zhang Y; Naren AP
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.